Biblio
Export 1711 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is C [Clear All Filters]
“Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.”, J Alzheimers Dis, vol. 104, no. 3, pp. 667-677, 2025.
, “ApoE ε4-dependent Alteration of CXCR3 CD127 CD4 T cells associates with elevated plasma neurofilament light chain in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251320123, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Chronic gingivitis increases the risk of early-onset Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251336259, 2025.
, “Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process.”, J Alzheimers Dis, p. 13872877251326291, 2025.
, “EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.”, J Alzheimers Dis, p. 13872877251327754, 2025.
, “EEG biomarkers for Alzheimer's disease: A novel automated pipeline for detecting and monitoring disease progression.”, J Alzheimers Dis, p. 13872877251327754, 2025.
, “Increased unedited Alu RNA patterns found in cortex extracellular vesicles in Alzheimer's disease resemble hippocampus vasculature Alu RNA editing patterns but not cortex Alu RNA editing patterns.”, J Alzheimers Dis, p. 13872877241313054, 2025.
, “Investigating the effects of 40 Hz sound stimulation on Alzheimer's disease pathways: Modulation of amyloid-β42 secretion, tau phosphorylation, phagocytosis, and autophagy.”, J Alzheimers Dis, p. 13872877251339774, 2025.
, “Investigating the effects of 40 Hz sound stimulation on Alzheimer's disease pathways: Modulation of amyloid-β42 secretion, tau phosphorylation, phagocytosis, and autophagy.”, J Alzheimers Dis, p. 13872877251339774, 2025.
, “Iron chelation by oral deferoxamine treatment decreased brain iron and iron signaling proteins.”, J Alzheimers Dis, p. 13872877241313031, 2025.
, “Leptin, adiponectin, body mass index, and incident cognitive impairment.”, J Alzheimers Dis, p. 13872877251326060, 2025.
, “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
, “Sex-specific effects of apolipoprotein E ε4 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period.”, J Alzheimers Dis, p. 13872877241313066, 2025.
, “African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181.”, J Alzheimers Dis, vol. 98, no. 1, pp. 221-229, 2024.
, “Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.”, J Alzheimers Dis, vol. 98, no. 1, pp. 151-161, 2024.
, “Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 901-912, 2024.
, “Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.”, J Alzheimers Dis, vol. 98, no. 3, pp. 755-772, 2024.
, “Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 333-343, 2024.
, “Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1375-1383, 2024.
, “The Association Between Neuropathological Lesions and Body Mass Index Is Independent of Cognitive Abilities.”, J Alzheimers Dis, vol. 101, no. 3, pp. 773-785, 2024.
, “BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.”, J Alzheimers Dis, vol. 101, no. s1, pp. S53-S78, 2024.
, “BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.”, J Alzheimers Dis, vol. 101, no. s1, pp. S53-S78, 2024.
, “Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 97, no. 1, pp. 229-237, 2024.
, “Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.”, J Alzheimers Dis, vol. 99, no. s2, pp. S187-S234, 2024.
,